表紙
市場調查報告書

已填充藥劑之注射器的主要製造商:2019年∼2029年 - 注射器、零組件的主要製造商/受託製造商 (CMO)的簡介、研究開發及收益預測

Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029: Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services

出版商 Visiongain Ltd 商品編碼 234469
出版日期 內容資訊 英文 224 Pages
商品交期: 最快1-2個工作天內
價格
已填充藥劑之注射器的主要製造商:2019年∼2029年 - 注射器、零組件的主要製造商/受託製造商 (CMO)的簡介、研究開發及收益預測 Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029: Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services
出版日期: 2019年08月30日內容資訊: 英文 224 Pages
簡介

全球已填充藥劑之注射器的市場規模今後,9.5%的年複合成長率 (CAGR) 預計持續擴大,2024年達到83億美元。

本報告提供已填充藥劑之注射器相關的主要製造商25家公司的評估與業界整體分析 (銷售業績、收益預測、成長率) 、研究開發趨勢等調查。

第1章 報告概要

第2章 簡介:已填充藥劑之注射器

  • 所謂已填充藥劑之注射器
  • 已填充藥劑之注射器製造商分類
    • 筆型注射器和自動注射器
    • 已填充藥劑之注射器的優點及缺點
  • 市場預測 (今後12年份)
  • 已填充藥劑之注射器市場部門之一的受託製造
  • 西方市場上的需求最大
  • 已填充藥劑之注射器市場:未來的主要趨勢
    • 企業整合的發展
    • 生技藥品、生物相似藥開發的發展
    • 家庭治療的增加
    • 安全性的需求增加伴隨的促進革新
    • 其他的藥物輸送技術的威脅

第3章 預填充式注射器製造市場主要企業

  • Becton, Dickinson, & Co (BD)
    • 產品系列
    • 近幾年的業績趨勢與策略展開情形
    • SWOT分析
    • 業績預測 (今後12年份)等
  • Gerresheimer AG
  • SCHOTT AG
  • Nipro Medical Corporation
  • Stevanato Group/Ompi
  • Vista Dental Products
  • 競爭分析
  • 高的進入障礙限制競爭
  • 其他廠商
    • Weigao Group Pharmaceutical Packaging Products Company
    • Roselabs Group

第4章 藥物注射零組件製造市場主要製造商

  • Aptar Stelmi
  • Datwyler Holding AG
  • West Pharmaceutical Services, Inc.
  • AbbVie Contract Manufacturing (AbbVie Inc.的子公司)
  • 競爭分析

第5章 筆型注射器、自動注射器的製造市場主要製造商

  • Wilhelm Haselmeier GmbH & Co. KG
  • Owen Mumford Ltd
  • SHL Group
  • Ypsomed Holding AG
  • 競爭分析

第6章 已填充藥劑之注射器的受託製造市場主要企業

  • Catalent
  • Vetter Pharmaceutical
  • 競爭分析
  • 其他企業
    • Laboratorios Farmaceuticos ROVI
    • Boehringer Ingelheim

第7章 結論

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0521

The Pre-Filled Device Manufacturing market is estimated to reach $8.3bn in 2024, growing at a CAGR of 9.5% throughout the forecast period.

The majority of revenues for pre-filled syringe manufacturers, including component manufacturers and pen injector/autoinjector manufacturers, came from developed markets.

How this 224-page report delivers:

Provides an overview and revenue forecasts of the global pre-filled injectable devices market from 2019 to 2029

Profiles of selected leading companies in the pre-filled injection device manufacturing:

  • Leading pre-filled syringe manufacturers
  • Leading pre-filled injectable component manufacturers
  • Leading pen injector and autoinjector manufacturers
  • Leading pre-filled injectable devices contract manufacturers

Companies profiled in this report:

  • Aptar Stelmi
  • Becton, Dickinson, & Co (BD)
  • Bespak Injectables
  • Boehringer Ingelheim
  • Catalent
  • Dätwyler Holding
  • Gerresheimer
  • Haselmeier
  • Laboratorios Farmacéuticos ROVI
  • Nemera.
  • Nipro
  • Ompi
  • Owen Mumford
  • Roselabs Group.
  • Schott
  • SHL Group
  • Tip-top
  • Vetter Pharma
  • Weigao Group Pharmaceutical Packaging Products Company
  • West Pharmaceutical Services.
  • Ypsomed

Information provided for the selected leading companies, when available:

  • Overview of the company
  • Historical Revenues
  • Revenue forecasts from 2019-2029
  • A SWOT analysis
  • A competitive analysis
  • Products & Services

Business Developments: Expansion, new products, mergers, acquisitions, collaborations.

This report also discusses the key trends in the pre-filled injection device manufacturing market.

  • 109 charts unavailable elsewhere

Visiongain's study is intended for anyone requiring commercial analyses for the pre-filled injection device manufacturing market. You find data, trends and predictions.

Buy our report today Top Pre-Filled Injection Device Manufacturers 2019-2029: Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Global Pre-Filled Injection Devices Market Overview
  • 1.2 Pre-Filled Injectable Devices Market Segmentation
  • 1.3 Top Pre-Filled Injectable Devices Market: An Overview
  • 1.4 How This Report Delivers
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report For?
  • 1.7 Methodology
  • 1.8 Frequently Asked Questions (FAQ)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2. Introduction to Pre-Filled Injectable Devices

  • 2.1 What are Pre-Filled Injectable Devices?
  • 2.2 Classification of Companies in the Pre-Filled Injectable Devices Market
    • 2.2.1 Pen Injectors and Autoinjectors
    • 2.2.2 Benefits and Weaknesses of Pre-Filled Injectors
  • 2.3 The Pre-Filled Injection Devices Market 2018-2029
  • 2.4 Contract Manufacturing as a Sector of the Pre-Filled Injectable Devices Market
  • 2.5 Demand on the Western Market is the Highest
  • 2.6 Key Trends in the Pre-Filled Injection Device Market 2018-2029
    • 2.6.1 Increased Market Consolidation
    • 2.6.2 Increased Development of Biologics and Biosimilars
    • 2.6.3 Rise in At Home Care
    • 2.6.4 Greater Demands for Safety Leading Innovation
    • 2.6.5 Threat from Other Drug Delivery Technologies

3. Leading Companies in the Pre-Filled Syringes Manufacturing Market 2019-2029

  • 3.1 Becton, Dickinson, & Co (BD)
    • 3.1.1 BD: Broad Portfolio of Syringe Products
      • 3.1.1.1 BD Hypak: The First Glass Pre-Filled Syringe Worldwide
      • 3.1.1.2 BD Sterifill
      • 3.1.1.3 BD Neopak
      • 3.1.1.4 BD Hylok for Viscous and Intravenous Drugs
      • 3.1.1.5 BD Uniject on the Emerging Market
      • 3.1.1.6 BD Physioject Autoinjector
      • 3.1.1.7 BD Nano 4mm Pen Needles
      • 3.1.1.8 BD Pen Injectors: BD Liquid Dry Injector and BD Reusable Pen
      • 3.1.1.9 BD Vystra Disposable Pen
      • 3.1.1.10 BD Proprietary Syringe Safety Systems
    • 3.1.2 R&D - New Product Launches Planned
    • 3.1.3 BD Acquires C.R. Bard
    • 3.1.4 BD's Pre-Filled Injection Historical Revenue 2017-2018
    • 3.1.5 Major Acquisitions and Focus on Core Competencies
    • 3.1.6 BD's Main Strategic Goals
    • 3.1.7 BD: Trend for Strategic Partnering
    • 3.1.8 BD SWOT Analysis, 2019-2029
      • 3.1.8.1 Collaboration and Expansion: Strategies for Growth and Rebranding
      • 3.1.8.2 BD Medical Revenue Forecast 2018-2029
  • 3.2 Gerresheimer AG
    • 3.2.1 Pre-Filled Syringe Manufacture at Gerresheimer
      • 3.2.1.1 RTF (Ready-To-Fill) Glass Syringes at Gerresheimer
      • 3.2.1.2 ClearJect RTF Plastic Syringes at Gerresheimer
      • 3.2.1.3 New German-made RTF ClearJect Syringe Combines the RTF Concept with Plastic
    • 3.2.2 Pen Injector Manufacture at Gerresheimer
    • 3.2.3 Gerresheimer Historical Revenue 2017-2018
    • 3.2.4 Strategic Acquisitions and Collaborations- Sensile Medical and West Pharmaceuticals
    • 3.2.5 Strategic Sale of Glass Tubing Business: Company Focus on Medical Devices and Primary Packaging
    • 3.2.6 Strong Growth in the Plastics and Devices Division with a Focus on Modernisation
    • 3.2.7 Standardisation as a Strategy
    • 3.2.8 Gerresheimer SWOT Analysis, 2019-2029
      • 3.2.8.1 Rapid Growth Planned for Emerging Markets
      • 3.2.8.2 Gerresheimer is Well-Placed for Biologics Growth and More Stringent Regulatory Changes
      • 3.2.8.3 Gerresheimer Plastics & Devices Market Revenue Forecast 2018 to 2029
  • 3.3 SCHOTT AG
    • 3.3.1 Schott Markets Glass and Plastic Pre-Filled Syringes
      • 3.3.1.1 SyriQ BioPure Launch for Sensitive Drugs
      • 3.3.1.2 Glass Syringes at Schott: Forma 3s and syriQ
      • 3.3.1.3 TopPac Polymer Syringes
      • 3.3.1.4 InJentle Syringes for Sensitive Drug Products
      • 3.3.1.5 Other New Innovations at Schott
    • 3.3.2 Schott Historical Revenue
    • 3.3.3 Expansion in Developed and Emerging Markets
      • 3.3.3.1 Growth in the Emerging Market
    • 3.3.4 Schott SWOT Analysis, 2019-2029
      • 3.3.4.1 Schott's Emerging Market Strategy
  • 3.4 Nipro Medical Corporation
    • 3.4.1 Overview of Nipro's Pre-Filled Syringe Portfolio
    • 3.4.2 New Products at Nipro
    • 3.4.3 Nipro is Expanding Globally
    • 3.4.4 Nipro SWOT Analysis, 2019-2029
      • 3.4.4.1 Responding to Rising Diabetes Incidence
  • 3.5 Stevanato Group/Ompi
    • 3.5.1 Ompi Markets Glass Pre-Filled Syringes and Cartridges
      • 3.5.1.1 EZ-Fill Syringe
      • 3.5.1.2 Extra High Quality (XQ) Syringes
      • 3.5.1.3 Acquisitions Collaborations and Innovations at Ompi
    • 3.5.2 Focused on Growth for Cartridges and Vials Manufacturing Especially in Emerging Markets
    • 3.5.3 Ompi SWOT Analysis, 2019-2029
      • 3.5.3.1 Ompi's Products for the Biologics Market
      • 3.5.3.2 Investing to Expand Capacity and Deal with Increasing Demand
  • 3.6 Vista Dental Products
    • 3.6.1 Vistra Markets Dental Pre-Filled Syringes
    • 3.6.2 Some of the company's products
      • 3.6.2.1 Best-Etch
      • 3.6.2.2 Porcelain Etch
      • 3.6.2.3 CHX-Plus
      • 3.6.2.4 Quick-Stat FREE
    • 3.6.3 Vista SWOT Analysis, 2019-2029
  • 3.7 Pre-Filled Syringe Manufacturers: Competitor Analysis 2019 to 2029
    • 3.7.1 The Need for Advanced Safety Systems
    • 3.7.2 Meeting the Demands of Biologics and Biosimilar Developers
    • 3.7.3 Product Portfolio Diversity
    • 3.7.4 What Demand is there in Emerging Markets?
  • 3.8 High Barriers to Market Entry Will Limit Competition to 2029
  • 3.9 Other Manufacturers of Interest in this Market
    • 3.9.1 Weigao Group Pharmaceutical Packaging Products Company
      • 3.9.1.1 Weigao's Historical Revenue 2016-2018
      • 3.9.1.2 Weigao Pre-Filled Syringes Revenue Forecast 2018-2029
    • 3.9.2 Roselabs Group

4. Leading Companies in the Pre-Filled Injectable Components Manufacturing Market

  • 4.1 Aptar Stelmi is a Pharma Packaging Specialist
    • 4.1.1 Aptar Stelmi's Pre-Fillwed Syringe Components
      • 4.1.1.1 Aptar Stelmi's Rigid Needle Shields
    • 4.1.2 Aptar: Strategically Increasing Market Access to the Autoinjector Market
    • 4.1.3 Aptar Stelmi's Expansion and Innovations
    • 4.1.4 Aptar Stelmi's Historical Revenue 2016-2018
    • 4.1.5 Aptar Stelmi SWOT Analysis, 2019-2029
  • 4.1.5.1 Regional Expansion is Important for Continued Growth
    • 4.1.6 Aptar Stelmi Revenue Forecast 2018-2029
  • 4.2 Dätwyler Holding AG
    • 4.2.1 Dätwyler's Pre-Filled Syringe Components
      • 4.2.1.1 Omniflex Coating: An Alternative to Silicone Oil
    • 4.2.2 Demand from Insulin Manufacturers Drives Revenue Growth 2016-2018
    • 4.2.3 Dätwyler is Focused on Strategic Acquisition and Expansion
    • 4.2.4 Growth in Emerging Markets
    • 4.2.5 Dätwyler SWOT Analysis, 2019-2029
    • 4.2.6 Dätwyler Healthcare Revenue Forecast 2018-2029
  • 4.3 West Pharmaceutical Services, Inc.
    • 4.3.1 West Manufactures Syringes and Syringe Components
      • 4.3.1.1 Daikyo Crystal Zenith: Licensed from Daikyo Seiko
      • 4.3.1.2 MixJect for Lyophilised Drugs
      • 4.3.1.3 West's Self-Injection Systems
      • 4.3.1.4 West Markets Three Safety Systems
      • 4.3.1.5 Innovation and Investment at West
    • 4.3.2 Recent Financial Performance
    • 4.3.3 Collaborations with Big Pharma for Product Development
    • 4.3.4 Expansion at West
    • 4.3.5 West SWOT Analysis, 2019-2029
    • 4.3.6 West Pharmaceutical Revenue Forecast 2018-2029
  • 4.4 AbbVie Contract Manufacturing, a division of AbbVie Inc.
    • 4.4.1 AbbVie' Contract Manufacturing Pre-Filled Syringes
      • 4.4.1.1 AbbVie' Contract Manufacturing Pre-Filled Syringes Capabilities
    • 4.4.2 AbbVie, Inc. Historical Revenue Growth 2016-2018
    • 4.4.3 AbbVie SWOT Analysis, 2019-2029
    • 4.4.4 AbbVie Revenue Forecast 2018-2029
  • 4.5 Pre-Filled Syringe Component Manufacturers: Competitor Analysis 2019-2029
    • 4.5.1 How Can Component Manufacturers React to Increased Safety Demands?
    • 4.5.2 Other Manufacturers of Interest in this Market
      • 4.5.2.1 tip-top.com Ltd.: Three Safety Products for Pre-Filled Syringes
      • 4.5.2.2 Nemera: Formed from Rexam's Sale of Healthcare Division
    • 4.5.3 Entering the Autoinjector Market
    • 4.5.4 Component Manufacturers Following Pre-Filled Syringe Manufacturers to Emerging Markets

5. Leading Companies in the Pen Injector and Autoinjector Manufacturing Market 2019-2029

  • 5.1 Wilhelm Haselmeier GmbH & Co. KG
    • 5.1.1 Haselmeier Markets Six Injection Systems
      • 5.1.1.1 Axis Pen Systems
      • 5.1.1.2 i-Pen: Haselmeier's Insulin Pen Injector
    • 5.1.2 Company Growth in Germany and India
    • 5.1.3 Haselmeier SWOT Analysis, 2019-2029
  • 5.2 Owen Mumford Ltd
    • 5.2.1 Autoinjector and Pen Injector Overview
      • 5.2.1.1 Autoject
      • 5.2.1.2 Autopen
      • 5.2.1.3 SimpleJect: Designed for RA Patients
    • 5.2.2 Innovative Products to Drive Growth
    • 5.2.3 Expanding in Established and New Markets
    • 5.2.4 Owen Mumford SWOT Analysis 2019-2029
  • 5.3 SHL Group
    • 5.3.1 SHL Manufactures a Broad Range of Injection Devices
      • 5.3.1.1 DAI Autoinjectors
    • 5.3.2 SHL Group Continues to Grow in Taiwan
    • 5.3.3 SHL Group SWOT Analysis, 2019-2029
  • 5.4 Ypsomed Holding AG
    • 5.4.1 Product Portfolio
      • 5.4.1.1 YpsoPen
      • 5.4.1.2 ServoPen
      • 5.4.1.3 UnoPen
      • 5.4.1.4 LyoTwist Injectors for Lyophilised Drugs
      • 5.4.1.5 Ypsomed Markets Two Autoinjectors
      • 5.4.1.6 Expansion at Ypsomed: Current and Future Plans
    • 5.4.2 Ypsomed: Financial Performance 2016-2018
    • 5.4.3 A Focus on Diabetes
    • 5.4.4 Ypsomed SWOT Analysis, 2019-2029
    • 5.4.5 Ypsomed Revenue Forecast 2019-2029
  • 5.5 Pen Injector and Autoinjector Manufacturers: Competitor Analysis 2018-2029
    • 5.5.1 A Competitive Market 2019-2029
    • 5.5.2 Other Manufacturers of Interest in this Market
      • 5.5.2.1 Bespak Injectables
    • 5.5.3 How Are Companies Differentiating Their Autoinjectors?
    • 5.5.4 Rising Demand in At-Home Care
      • 5.5.4.1 Specific Demands in RA and MS
    • 5.5.5 Contract Manufacturing for Autoinjectors

6. Leading Companies in the Contract Pre-Filled Injectable Devices Manufacturing Market 2018-2029

  • 6.1 Catalent
    • 6.1.1 Pre-Filled Syringe Contract Manufacturing Capabilities
    • 6.1.2 Catalent Offers an Autoinjector
    • 6.1.3 Innovations at Catalent
    • 6.1.4 Catalent Pharma Solutions: Financial Performance 2016-2018
    • 6.1.5 Expanding Filling Capacity for Clinical Trial Materials
    • 6.1.6 Acquisitions and Collaborations
    • 6.1.7 Catalent SWOT Analysis 2019-2029
    • 6.1.8 Catalent Biologics and Speciality Drug Delivery Revenue Forecast 2018-2029
  • 6.2 Vetter Pharmaceutical
    • 6.2.1 Vetter is an Injectable Manufacturing Specialist
    • 6.2.2 Vetter's Ten-Year Expansion Plan
    • 6.2.3 New Services and Collaborations
  • 6.3 The Competitive Outlook for Leading CMOs in the Market 2019-2029
    • 6.3.1 Biologics, Lyophilisation, and Dual-Chamber Syringes
    • 6.3.2 An Increasingly Competitive Market
    • 6.3.3 Important of Keeping Up with Regulations
  • 6.4 Other Pre-Filled Syringe Contract Manufacturers 2018
    • 6.4.1 Laboratorios Farmacéuticos ROVI
      • 6.4.1.1 ROVI CM's Pre-Filled Syringe Capabilities
    • 6.4.2 Boehringer Ingelheim

7. Conclusions

  • 7.1 Outlook for the Pre-Filled Injection System Market 2018-2029
  • 7.2 Outlook for Leading Pre-Filled Injection System Manufacturers 2019-2029
    • 7.2.1 How Will Leading Companies' Revenues Grow to 2029?
  • 7.3 The Future of the Pre-Filled Medical Devices Market
  • Appendices
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain report evaluation form

List of Tables

  • Table 2.1 Total Pre-Filled Device Manufacturing Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 2.2 Pre-Filled Injection Device Market by Region, 2018
  • Table 2.3 Pre-Filled Injection Device Market: STEP Analysis, 2018-2029
  • Table 2.4 Selected Recent Acquisitions in the Pre-Filled Injection Devices Industry, 2014-2019
  • Table 3.1 BD Overview, 2019
  • Table 3.2 BD Revenue by Division ($m), 2018
  • Table 3.3 BD Historical Revenue by Division ($m), AGR (%), 2017-2018
  • Table 3.4 Medical Division Revenue ($m), 2017-2018
  • Table 3.5 BD: Pharmaceutical Systems Revenue ($m), AGR (%), CAGR (%), 2016-2018
  • Table 3.6 BD Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 3.7 BD Pharmaceutical Systems Revenue Forecast ($m), AGR (%), CAGR (%), 2018-2029
  • Table 3.8 Gerresheimer: Employees by Region, 2018
  • Table 3.9 Gerresheimer Overview, 2019
  • Table 3.10 Gerresheimer: Revenue by Division ($m), AGR (%), 2017-2018
  • Table 3.11 Gerresheimer Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 3.12 Gerresheimer Plastics and Devices: Revenue Forecast ($m), AGR (%), CAGR (%), 2018-2029
  • Table 3.13 Schott Overview, 2019
  • Table 3.14 Schott Revenue ($m), AGR (%), CAGR (%), 2016-2018
  • Table 3.15 Schott Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 3.16 Nipro Overview, 2019
  • Table 3.17 Nipro Revenue ($m), AGR (%), CAGR (%), 2016-2018
  • Table 3.18 Nipro Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 3.19 Stevanato Group/Ompi Overview, 2019
  • Table 3.20 Ompi Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 3.21 Vista Dental Product: Overview, 2019
  • Table 3.22 Vista Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 3.23 Pre-Filled Syringes: Leading Product Comparisons, 2019
  • Table 3.24 Leading Pre-Filled Syringe Manufacturers: Comparative Product Ranges, 2019
  • Table 3.25 Weigao Group Pharmaceutical Packaging Products Company Overview, 2019
  • Table 3.26 Weigao: Pre-Filled Syringes Revenue ($m), AGR (%), CAGR (%), 2016-2018
  • Table 3.27 Weigao: Revenue Forecast ($m), AGR (%), CAGR (%), 2018-2029
  • Table 3.28 Roselabs Group Overview, 2019
  • Table 4.1 Aptar Stelmi Overview, 2019
  • Table 4.2 Aptar Stelmi - Pharma Injectables: Revenue ($m), AGR (%), CAGR (%), 2016-2018
  • Table 4.3 Aptar Stelmi Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 4.4 Aptar Stelmi: Revenue Forecast ($m), AGR (%), CAGR (%), 2018-2029
  • Table 4.5 Dätwyler Overview, 2018
  • Table 4.6 Dätwyler: Sealing Solutions Revenue ($m), AGR (%), CAGR (%), 2016-2018
  • Table 4.7 Dätwyler Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 4.8 Dätwyler- Sealing Solutions: Revenue Forecast ($m), AGR (%), CAGR (%), 2018-2029
  • Table 4.9 West Pharmaceutical Services Overview, 2019
  • Table 4.10 West: Selected Pharmaceutical Industry Partners, 2019
  • Table 4.11 West: Revenue by Division ($m), 2016-2018
  • Table 4.12 West Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 4.13 West Pharmaceuticals: Revenue Forecast ($m), AGR (%), CAGR (%), 2018-2029
  • Table 4.14 AbbVie Overview, 2019
  • Table 4.15 AbbVie: Revenue ($m), AGR (%), CAGR (%), 2016-2018
  • Table 4.16 AbbVie: Region Revenue ($m), 2016-2018
  • Table 4.17 AbbVie Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 4.18 AbbVie: Revenue Forecast ($m), AGR (%), CAGR (%), 2018-2029
  • Table 4.19 Tip-top Overview, 2019
  • Table 4.20 Nemera Overview, 2019
  • Table 5.1 Haselmeier Overview, 2019
  • Table 5.2 Selected Partners for the i-Pen, 2019
  • Table 5.3 Haselmeier Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 5.4 Owen Mumford Overview, 2019
  • Table 5.5 Selected Autoject Range Products, 2019
  • Table 5.6 Owen Mumford Pre-Filled Injection Devices: SWOT Analysis, 2019 to 2029
  • Table 5.7 SHL Group Overview, 2019
  • Table 5.8 SHL Group: Pen Injectors and Autoinjectors, 2019
  • Table 5.9 SHL Group Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 5.10 Ypsomed Overview, 2019
  • Table 5.11 Ypsomed: Pen Injectors and Autoinjectors, 2019
  • Table 5.12 Selected Pharmaceutical Partners for Ypsomed's Pen Injectors, 2019
  • Table 5.13 LyoTwist Injectors Available, 2019
  • Table 5.14 Ypsomed: Revenue by Division ($m), CAGR (%), 2016-2018
  • Table 5.15 Ypsomed Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 5.16 Ypsomed Delivery Devices: Revenue Forecast ($m), AGR (%), CAGR (%), 2018-2029
  • Table 5.17 Pen Injectors: Selected Product Comparisons, 2019
  • Table 5.18 Autoinjectors: Selected Product Comparisons, 2019
  • Table 5.19 Selected Other Pen Injector and Autoinjector Manufacturers, 2017
  • Table 5.20 Bespak Injectables Overview, 2019
  • Table 6.1 Catalent Overview, 2019
  • Table 6.2 Catalent: Revenue by Division ($m), CAGR (%), 2016-2018
  • Table 6.3 Catalent Pre-Filled Injection Devices: SWOT Analysis, 2019-2029
  • Table 6.4 Catalent Biologics and Speciality Drug Delivery Division: Revenue Forecast ($m), AGR (%), CAGR (%), 2018-2029
  • Table 6.5 Vetter Pharma Overview, 2019
  • Table 6.6 Leading Pre-Filled Syringe CMOs: Company Comparison, 2019
  • Table 6.7 Laboratorios Farmacéuticos ROVI Overview, 2019
  • Table 6.8 Laboratorios Farmacéuticos ROVI: Revenue ($m), AGR (%), CAGR (%), 2016-2018
  • Table 6.9 Boehringer Ingelheim Overview, 2019

List of Figures

  • Figure 1.1 Global Pre-Filled Injectable Devices Market Segmentation Overview, 2019
  • Figure 2.1 Total Pre-Filled Device Manufacturing Market Forecast: Revenues ($m), 2018-2029
  • Figure 2.2 Pre-Filled Injection Device Market by Region, 2018
  • Figure 3.1 BD Revenue by Division ($m), 2018
  • Figure 3.2 BD Historical Revenue by Division ($m), 2017-2018
  • Figure 3.3 BD: Pharmaceutical Systems Revenue ($m), 2016-2018
  • Figure 3.4 BD Pharmaceutical Systems Revenue Forecast ($m), 2018-2029
  • Figure 3.5 Gerresheimer: Employees by Region, 2018
  • Figure 3.6 Gerresheimer: Revenue by Division ($m), 2017-2018
  • Figure 3.7 Gerresheimer Plastics and Devices: Revenue Forecast ($m), 2018-2029
  • Figure 3.8 Schott Revenue ($m), 2016-2018
  • Figure 3.9 Nipro Revenue ($m), 2016-2018
  • Figure 3.10 Weigao: Pre-Filled Syringes Revenue ($m), 2016-2018
  • Figure 3.11 Weigao: Revenue Forecast ($m), 2018-2029
  • Figure 4.1 Aptar Stelmi - Pharma Injectables: Revenue ($m), 2016-2018
  • Figure 4.2 Aptar Stelmi: Revenue Forecast ($m), 2018-2029
  • Figure 4.3 Dätwyler: Sealing Solutions Revenue ($m), 2016-2018
  • Figure 4.4 Dätwyler Healthcare: Revenue Forecast ($m), 2018-2029
  • Figure 4.5 West: Revenue by Division ($m), 2016-2018
  • Figure 4.6 West Pharmaceuticals: Revenue Forecast ($m), 2018-2029
  • Figure 4.7 Abbvie: Revenue ($m), 2016-2018
  • Figure 4.8 AbbVie: Revenue Forecast ($m), 2018-2029
  • Figure 5.1 Ypsomed: Revenue by Division ($m), 2016-2018
  • Figure 5.2 Ypsomed Delivery Devices: Revenue Forecast ($m), 2018-2029
  • Figure 6.1 Catalent: Employees by Region, 2018
  • Figure 6.2 Catalent: Revenue by Division ($m), 2016-2018
  • Figure 6.3 Catalent Biologics and Speciality Drug Delivery Division: Revenue Forecast ($m), 2018-2029
  • Figure 6.4 Laboratorios Farmacéuticos ROVI: Revenue ($m), 2016-2018

COMPANIES LISTED:

  • AbbVie
  • Actavis
  • AdvalTech
  • Aesica
  • Agência Nacional de Vigilância Sanitária (ANVISA) (Brazil)
  • Albany Molecular Research (AMRI)
  • AluPlast
  • Amcor Glass Tubing (part of Nipro)
  • American Stelmi (part of Aptar Stelmi)
  • Amgen
  • Amylin Pharmaceuticals
  • Antares Pharma
  • ANVISA
  • Apax Partners
  • Aptar Stelmi
  • AptarGroup
  • Aptuit
  • AstraZeneca
  • Aucta Pharmaceuticals
  • B. Braun Medical
  • Balda Group
  • Baxter
  • Baxter BioPharma Solutions (part of Baxter)
  • Baxter International
  • Bayer
  • BD Medico
  • Becton, Dickinson & Co. (BD)
  • Berlin-Chemie
  • Berry Plastics Group
  • Bespak
  • Biocon
  • Biogen Idec
  • Bionime
  • Blackstone Group
  • Boehringer Ingelheim
  • Boehringer Ingelheim BioXcellence
  • Bristol-Myers Squibb
  • C.R. Bard
  • Cambridge Consultants
  • CAPS (Central Admixture Pharmacy Services)
  • Cardinal Health
  • Cardium Therapeutics
  • CareFusion
  • Carl Zeiss Foundation
  • Carmel Pharma
  • Catalent
  • CeifiT
  • Cellular Research
  • Centers for Disease Control and Prevention (CDC)
  • Centor
  • Clere (part of Ompi)
  • Columbia Engineered Rubber
  • ConnectMeSmart GmbH
  • Consort Medica
  • Corning
  • Crucell Spain
  • Daikyo Seiko
  • Dätwyler
  • Dätwyler Holding
  • Debiopharm Group
  • Diagenode
  • Disetronic Group
  • Disetronic Group (part of Roche)
  • Dong-A Pharmaceutical
  • Dr. Reddy's Laboratories
  • DS WorldMed
  • Duoject
  • DuPont
  • Elcam Medical
  • Eli Lilly
  • EMA (European Medicines Agency)
  • European Commission
  • European Medicines Agency (EMA)
  • Euticals
  • EVER Nuro Pharma
  • Federal Commission for Protection against Health Risks
  • Ferring Pharmaceuticals
  • Food and Drug Administration (FDA) (US)
  • Fresenius
  • Future Injection Technologies
  • Gadea Pharmaceutical Group
  • GenCell Biosystems
  • Genentech
  • Genovi Pharmaceuticals Limited
  • GeroPharm
  • Gerresheimer
  • GSK
  • Hankook Sealtech
  • Hanmi Pharmaceutical Co
  • Haselmeier
  • HealthPrize
  • HEKUMA
  • Helvoet Pharma
  • Hospira
  • Hospira One2One (part of Hospira)
  • Hyaluron Contract Manufacturing (HCM, part of AMRI)
  • Incepta Pharmaceuticals
  • Injectronics
  • Insulet
  • J&J
  • Jabil Circuit
  • Janssen Biotech
  • Japanese MHLW (Ministry for Health, Labour, and Welfare)
  • Johnson & Johnson
  • Juniper Pharmaceuticals
  • Korea Food and Drug Administration (KFDA)
  • Laboratorios Farmacéuticos ROVI
  • LifeScan
  • Lupin
  • McKesson
  • Medicines and Healthcare Products Regulatory Agency (MHRA) (UK)
  • MedImmune (part of AstraZeneca)
  • Medimop Medical Projects (part of West Pharmaceutical Services)
  • Medtronic
  • Menarini Group
  • Merck & Co.
  • Merck KGaA
  • MG Sterile Products (part of Nipro)
  • MGlas
  • Ministry of Health, Labor and Welfare (MHLW) (Japan)
  • MJ Biopharm
  • Montagu
  • Montagu Private Equity
  • NanoPass Technologies
  • Nemera
  • Neutral Glass and Allied Industries
  • Nipro
  • Nipro Europe (part of Nipro)
  • Nipro Glass (part of Nipro)
  • Nipro Medical (part of Nipro)
  • Nipro North America
  • Novartis
  • Novo Nordisk
  • Nuova Ompi (Formerly Ompi, Italian part of Stevanato Group)
  • Nycomed
  • Nycomed (part of Takeda)
  • Nypro
  • Occupational Safety and Health Administration (OSHA) (US)
  • Ompi
  • Opiant Pharmaceuticals
  • Optrel (part of Stevanato Group)
  • Origom
  • Osu Biopharmaceutical Manufacturing
  • Oval Medical
  • Owen Mumford
  • PA Consulting Group
  • Palatin Technologies
  • Parker Institute
  • PATH
  • Pema Holding
  • Pfizer
  • Pharma-Pen (part of West Pharmaceutical Services)
  • PharmaTap
  • Pharmstandard
  • Phillips Medisize
  • Plastef Investissements
  • Polfa Tarchomin
  • Primequal
  • Primoceler Oy
  • QuiO
  • Revolutions Medical
  • Rexam
  • Roche
  • Roselabs Bioscience (part of Roselabs Group)
  • Roselabs Group
  • Roselabs Polymers (part of Roselabs Group)
  • ROVI CM (part of Laboratorios Farmacéuticos ROVI)
  • Rumpler Technologies
  • Safety Syringes (part of BD)
  • Sandoz (part of Novartis)
  • Sanex Packaging Connections
  • Sanofi
  • Sanofi Pasteur
  • Savient Pharmaceuticals
  • Scandinavian Health Ltd (SHL Group)
  • Schering-Plough (part of Merck & Co.)
  • Schott
  • Schott Kaisha
  • Sealing Technologies
  • Sensile Medical
  • Sentry BioPharma Services
  • Shandong Weigao Group Medical Polymer Company
  • Shanghai Fosun Pharmaceutical
  • Shire
  • SHL Group
  • Smiths Group
  • Spami (part of Stevanato Group)
  • Square Pharmaceuticals
  • Stallergenes
  • Stelmi Asia (part of Aptar Stelmi)
  • Stevanato Group
  • Sungwon Medical
  • Swedish Orphan Biovitrum (Sobi)
  • Taisei Kako
  • Teva
  • Teva Pharmaceutical Industries
  • The Medical House
  • The Parker Institute (part of The Parker Foundation)
  • The Tech Group (part of West Pharmaceutical Services)
  • ThinFilm
  • Tip-Top
  • Tissue Repair Company (part of Cardium Therapeutics)
  • Tolmar
  • Tonghua Dongbao
  • Triveni Polymers
  • UCB
  • UK Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Unilife
  • US Agency for International Development
  • Valerius Biopharma
  • Vetter Pharma
  • Watson Pharmaceutical
  • Weigao Group Pharmaceutical Packaging Products Company
  • West Company Mexico
  • West Pharmaceutical India Packaging Private (part of West Pharmaceutical Services)
  • West Pharmaceutical Services
  • Wockhardt
  • World Health Organization (WHO)
  • WW Medical and Healthcare Company Limited
  • Ypsomed
  • Zeon Corporation
  • Zhongding Sealtech